Precision BioSciences Inc (DTIL)

[swampboots]

I think it is an interesting attempt to place DTIL's CART-T platform in comparison to its "peers".
but a highly impossible task without sorting out the 1000's of new studies each month in this field. I am relying on insider buying, fruitful handshakes with some big drug Companies, the Co's cash burn position, as well as the shortness of time since last pipe dilution.
With no scientific credentials I read dozens of new studies a day in the cancer field, and
try to imitate a journalist in my digestions of the information relayed as tidy summaries.
And weekly for sure new tweaks to the Cart-T arena are proposed, some to reduce costs, improve accuracy, limit mis-maufacturing mistakes in the expensive customizing of their applications, as microscopic contamination difficult to contain or measure.. In addition to toying with new discovered proteins which must be suppressed, added or mingled to make the CART-T platform more effective. It is a moving target where one simple new discovery can weigh heavily on the ultimate effectiveness toward endpoint mastery.......To repeat I have to assume insiders and big drug Co.'s offering some of their risk , favors the odds to me by relying on better eyes concluding more probable credibility, as their surveilance is closer to the microscope sorting out the unresolved challenges I am not in the loop to know..